Cardiotoxic effects of the antiarrhythmic rhythmidazol and their correction by suphan, befol, and their combinations

The antiarrhythmic rhythmidazol produces a cardiotoxic effect that can be corrected by suphan, befol, and their combinations, as evidenced by normalization of ultrastructural organization of cardiomyocytes and myocardial oxygen consumption by these drugs.[PUBLICATION ABSTRACT]

Saved in:
Bibliographic Details
Published inBulletin of experimental biology and medicine Vol. 124; no. 6; pp. 1189 - 1193
Main Authors Galenko-Yaroshevskii, P. A., Skibitskii, V. V., Boldin, V. B., Seredenko, M. M., Khankoeva, A. I., Uvarov, A. V.
Format Journal Article
LanguageEnglish
Published New York Springer Nature B.V 01.12.1997
Subjects
Heart
Oxygen
Online AccessGet full text

Cover

More Information
Summary:The antiarrhythmic rhythmidazol produces a cardiotoxic effect that can be corrected by suphan, befol, and their combinations, as evidenced by normalization of ultrastructural organization of cardiomyocytes and myocardial oxygen consumption by these drugs.[PUBLICATION ABSTRACT]
ISSN:0007-4888
1573-8221
DOI:10.1007/BF02445116